Benchmark initiated coverage of MiniMed (MMED) with a Buy rating and $20 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMED:
- MiniMed 780G system software licensed by Health Canada
- Medtronic price target lowered to $95 from $108 at Jefferies
- William Blair med tech analyst holds an analyst/industry conference call
- Medtronic price target lowered to $95 from $105 at Stifel
- Goldman Sachs Says Markets Stay Strong – Picks 2 ‘Strong Buy’ Stocks to Consider